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A B S T R A C T
Purpose: Multiple Sclerosis (MS) is likely to cause dysfunction of neural circuits between brain regions
increasing brain working load or a subjective overestimation of such working load leading to fatigue symptoms.
The aim of this study was to investigate if saccades can reveal the eﬀect of fatigue in patients with MS.
Methods: Patients diagnosed with MS (EDSS < =3) and age matched controls were recruited. Eye movements
were monitored using an infrared eyetracker. Each participant performed 40 trials in an endogenous generated
saccade paradigm (valid and invalid trials). The fatigue severity scale (FSS) was used to assess the severity of
fatigue. FSS scores were used to deﬁne two subgroups, the MS fatigue group (score above normal range) and the
MS non-fatigue. Diﬀerences between groups were tested using linear mixed models.
Results: Thirty-one MS patients and equal number of controls participated in this study. FSS scores were above
the normal range in 11 patients. Diﬀerences in saccade latency were found according to group (p < 0.001) and
trial validity (p=0.023). Diﬀerences were 16.9 ms, between MS fatigue and MS non-fatigue, 15.5 ms between
MS fatigue and control. The mean diﬀerence between valid and invalid trials was 7.5 ms. Diﬀerences in saccade
peak velocity were found according to group (p < 0.001), the diﬀerence between MS fatigue and control was
22.3°/s and between MS fatigue and non-fatigue was 12.3°/s. Group was a statistically signiﬁcant predictor for
amplitude (p < 0.001). FSS scores were correlated with peak velocity (p=0.028) and amplitude (p=0.019).
Conclusion: Consistent with the initial hypothesis, our study revealed altered saccade latency, peak velocity and
amplitude in patients with fatigue symptoms. Eye movement testing can complement the standard inventories
when investigating fatigue because they do not share similar limitations. Our ﬁndings contribute to the
understanding of functional changes induced by MS and might be useful for clinical trials and treatment
decisions.
1. Introduction
Multiple Sclerosis (MS) is a neurodegenerative disease character-
ized by demyelination and consequent reduction of neural conduction
within the central nervous system leading to functional impairments
(Archibald and Fisk, 2000; Kurtzke, 1983). MS represents the main
cause of disability in non-traumatic neurological diseases in young
adults (Sadovnick and Ebers, 1993) aﬀecting up to 1 in 1000 people in
some countries (Kingwell et al., 2013). In the Portuguese population a
study from our group has found a prevalence of 40 cases per 100,000
inhabitants (Figueiredo et al., 2015). Consequences of MS go beyond
the physical disability and symptoms of fatigue and depression are
commonly reported at any stage of the disease (Janardhan and Bakshi,
2002). The MS Council, cited by Kos et al. (2008), deﬁne fatigue as “a
subjective lack of physical and/or mental energy that is perceived by
the individual or caregiver to interfere with usual and desired
activities”. Distressing symptoms of physical and mental fatigue have
detrimental implications on career, employment and other activities,
reducing signiﬁcantly the quality of life of those aﬀected (Frohman
et al., 2005; Janardhan and Bakshi, 2002).
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Fatigue inventories are the most commonly used instruments to
quantify, albeit subjectively, fatigue levels and their impact (Dittner,
Wessely, & Brown). Two commonly used inventories in MS are the
Fatigue Severity Scale (FSS) and the Modiﬁed Fatigue Impact Scale
(MFIS) (Dittner et al., 2004). However, according to a review by
Chaudhuri and Behan in 2004, these inventories have some limitations.
For example, they can introduce bias into a study population because of
participants' knowledge that they are being studied (Hawthorne eﬀect)
(Chaudhuri and Behan, 2004). Given these limitations of inventories,
alternative methods have been tried.
Some studies tried an objective characterization of fatigue using
magnetic resonance imaging (Filippi et al., 2002; Genova et al., 2013;
Mainero et al., 1999). In a study by Filippi et al., 2002 it was speculated
that mental fatigue, in people with symptoms, might be explained by an
increased activation of the cortical areas involved in attention. In a
diﬀerent study by the same group, authors hypothesized that some
cortical reorganization might take place in patients with fatigue in
order to maintain the functional capacity of the damaged brain (Rocca
et al., 2002). This is also the most likely explanation for the lack of
correlation between perceived fatigue and functional performance
(Beatty et al., 2003). In people with reorganization, fatigue might
become a “trait” contrary to what is expected in those without fatigue in
which it can be considered a “state”. Some authors distinguish “trait
fatigue” from “state fatigue” (Genova et al., 2013; Parmenter et al.,
2003; Roelcke et al., 1997). Genova et al. (2013) deﬁne “state” fatigue
as a transient condition, which can change with time and can ﬂuctuate
based on both internal and external factors. State fatigue can be
measure with, for example, a visual analogue scale. “Trait” fatigue
refers to a more stable state in an individual and is not likely to change
signiﬁcantly over time. Trait fatigue is normally self-reported and can
be quantiﬁed with the FSS scale (Genova et al., 2013). In this manu-
script, when the word fatigue is used alone we refer to trait fatigue.
Recent reports gave evidence that saccadic eye movements can be
used to study fatigue in MS (Finke et al., 2012; Matta et al., 2009).
However, these ﬁndings need conﬁrmation and other approaches to
avoid limitations of previous studies. In the case of the study by Matta
et al. (2009), all patients have been diagnosed with internuclear
ophthalmoplegia (INO). Because of that, the authors speculate that
mechanic disconjugacy of the eye movements observed in their
participants is likely to be measuring not only fatigue but also
oculomotor problems (Matta et al., 2009). In the study by Finke
et al. (2012), patients were divided according with their FSS score in
MS fatigue and MS non-fatigue (Finke et al., 2012). The MS fatigue
group showed longer saccade latencies than the other two groups (non-
fatigue and control) in a 10 min exogenous (reﬂexive) saccade task.
Peak velocity and amplitude in fatigued patients were similar to
controls and non-fatigued patients at the beginning of the task, but
that changed over time. This study showed that patients with fatigue
symptoms are more prone to fatigability but did not clarify if saccades
would assess directly fatigue symptoms. Also, it is uncertain if this task
would assess, physical mental, or both types of fatigue. It seems,
therefore, that diﬀerent paradigms might provide further insight in
how fatigue aﬀects saccades.
Endogenous saccades (goal-oriented) require additional top-down
control (Liversedge et al., 2011; Walker et al., 1997, 1995, 2000). The
neural systems controlling visual attention appear to overlap with those
controlling eye movements and is not possible to make an eye move-
ment without making a shift of attention (Kristjánsson, 2011; Summer,
2011). There is evidence from positron emission tomography that
metabolic activity in the frontal lobes and the anterior cingulate is
altered in patients with fatigue symptoms. These are areas also
involved in attention, executive functions and eye movements planning
(Liversedge et al., 2011; Summer, 2011). Therefore, endogenous
saccade paradigms as the one used by Fielding et al. (2009) should
be able to distinguish patients with fatigue from those without fatigue.
A saccade paradigm combining the presentation of an endogenous
attentional cue (that can be “valid” or “invalid”, see Refs (Posner
Cuieng Task, 2016; Posner, 1980)) with the execution of an exogenous
saccade (in response to the appearance of a visual target) is likely to
show increased latencies in fatigued patients due to attention problems
associated with fatigue (Posner Cuieng Task, 2016; Posner, 1980).
Moreover, fatigue would cause reduction in peak velocity mostly due to
altered neural activity in areas frontal cortical areas and the anterior
cingulate cortex (Liversedge et al., 2011). Therefore, the aim of this
study was to investigate endogenous generated saccades in MS patients
with fatigue symptoms. We hypothesized that patients with fatigue
would show changes in oculomotor performance, in particular in-
creased latency and reduced peak velocity, reﬂecting trait fatigue.
2. Methods
2.1. Participants
MS participants were recruited from the local hospital by their
neurologist (author JJC). The inclusion criteria for MS participants
were: age between 18 and 45 years old, relapsing remitting course,
early stages of disease severity as measured by the Expanded Disability
Status Scale ≤3 (Kurtzke, 1983), normal or corrected to normal
binocular visual acuity and not medicated to fatigue symptoms.
Exclusion criteria were: on-going relapse/relapse in the previous
month, presence of clinically diagnosed cognitive impairment, history
of traumatic brain injury and/or stroke, depression (self-reported or
detected during the study using the Beck Depression Inventory (Beck
et al., 1988)), and clinically visible oculomotor abnormalities (e.g.,
nystagmus or INO). Controls were subject to equivalent exclusion
criteria. The institutional ethics committee at University of Minho
reviewed the study. All participants were fully informed about the aim
of the study and procedures involved, all provided free informed
consent.
2.2. Equipment
Eye movements were monitored using a binocular eyetracker
running at 250 Hz (RED250, SMIGmb, Teltow, Germany). The eye-
tracker has a spatial resolution < 0.4°, is controlled with iView X
software (v2.8, August 2011, SMIGmb, Teltow, Germany) and stimuli
were presented on a 22 in. LCD monitor running at 60 Hz (Dell
P2210). The system is formed of two computers connected by a high
speed Ethernet. A computer controlled the eyetracker and a second
computer controlled the stimulus presentation. A Matlab SDK provided
by SMI and elements of the Psychophysics toolbox were used for
running the experiment (Brainard, 1997; Pelli, 1997). Code for data
analysis was also written in Matlab (The MathWorks, Inc., Natick, MA,
USA).
2.3. Procedure for measuring saccades
Experiments were performed in a dimly lit room (~10 lux) and
stimulus Michelson contrast was 90%. One or two blocks of 8 practice
trials were performed before data collection to make participants
familiar with calibration and with the task. A 5-point calibration
procedure was applied, only participants with calibration accuracy
(mean deviation for the expected position) of 1° or less in x-axis and y-
axis were considered. Participants were seated 70 cm from the monitor
with their head restrained with a headband attached to the seat, as
shown in Fig. 1. Saccades were performed 10° to the left or to the right
of the ﬁxation target using the paradigm shown in Fig. 1. The paradigm
consisted of 3 steps. In step 1 subjects had to ﬁxate a centrally located
target (cross) during 850 ms, in step 2 the cross was replaced by a left
or right pointing arrow illuminated by 500 ms and in step 3, subjects
were presented with a peripheral target (cross) duration 1500 ms,
appearing at 10° to the left or the right of the ﬁxation target (in a
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random way). Trials were deﬁned as “valid” if the arrow in step 2 was
pointing in the same direction as the target, shown in Fig. 1, and
“invalid” if the arrow was pointing in the opposite direction of the
target. Participants were instructed to: “ﬁxate the central cross ﬁrst,
keep ﬁxating the arrow until a peripheral target appears and then
look at the target as quickly as possible”, the target was a 30×30 mm
cross. Each subject performed 40 trials, 80% valid trials and 20%
invalid trials, this division was suggested by Posner (1980). See video
still for an example of the paradigm.
Supplementary material related to this article can be found online
at http://dx.doi.org/10.1016/j.msard.2017.01.014.
2.4. Neuropsychological inventories
Fatigue severity was assessed with the Fatigue Severity Scale (FSS).
The FSS scale consists of 9 questions about the severity of fatigue
symptoms, categorized from strongly disagrees to strongly agrees by
the subject (Krupp et al., 1989). Higher scores represent higher fatigue
severity. The impact of fatigue in daily living was assessed through the
Modiﬁed Fatigue Impact Scale (MFIS). In this inventory patients rate
the extent to which fatigue has aﬀected their life in the past 4 weeks on
a questionnaire consisting of 10 “physical” items, 10 “cognitive” items,
and 20 “social” items, with 0 indicating “no problem” and 4 indicating
“extreme problem” (Kos et al., 2005) (Portuguese version validated
versions by Gomes (2011) Available: http://hdl.handle.net/1822/
17841)). Higher scores represent higher fatigue impact. Both
inventories have normative data for the Portuguese population that
are 33 (SD=8.7) for the FSS and 23 (SD=12) for the MFIS. Results
from the MS group were compared with the normative values and these
inventories were only applied to patients.
A general test of cognitive functioning, the MOCA-Montreal
Cognitive Assessment, was also applied. This test provides information
about executive functions, visuospatial ability, working memory and
attention (Hajek et al., 1997). The global MOCA score corresponds to
the sum of correct responses in each dimension and higher scores
correspond to better cognitive functioning (Nasreddine et al., 2005).
The expected value for the Portuguese population is 26.4 (SD=2.2)
(Freitas et al., 2010).
Symbol Digit Modalities Test (SDMT) was used to evaluate
neurocognitive functions that underlie many substitution tasks, in-
cluding attention, visual scanning, and motor speed (Sheridan et al.,
2006). In this test subjects are presented with a key that includes 9
numbers, each one paired with a diﬀerent symbol. Below the key is an
array of these same symbols in a pseudorandom order paired with
empty spaces. Subjects must then provide the correct numbers that
accompany the symbols as indicated in the key. The number of correct
paired symbols corresponds to the total score. Higher scores corre-
spond to better performance (da Costa Pinto, 2004; Sheridan et al.,
2006).
2.5. Eye movements analysis
Eye movements were collected binocularly with the point-of-regard
(POR) information being: (POR-RE+POR-LE)/2. Saccadic variables
analysed were latency, peak velocity and amplitude. Latency represents
the time from stimulus appearance until the reaction of the eyes
moving towards the target. Amplitude was measured as the absolute
distance in degrees from the start position to the end position of the
eye. Both amplitude and latency are represented in Fig. 2.
For analysed trials, saccade detection was performed after smooth-
ing xy positions with a 5 sample moving average. This method has been
proposed by others to reduce noise (Engbert and Kliegl, 2003). After
smoothing, eye velocity and acceleration were computed, saccades were
detected using the velocity threshold of 30°/s and/or acceleration
Fig. 1. The ﬁgure shows the endogenous generated saccades paradigm and the head-
band restraining head movements (top-left). Continuous ﬁxation during 10 monitor
frames in a gaze-contingent ﬁxation box in the middle of the screen (200×200 pixel) was
required before each trial. Each trial started in step 1 during which a central ﬁxation
cross presented for 850 ms followed by step 2 in which an arrow (cue) was presented for
500 ms and in step 3 the target appeared 10° to the right or left of the central cue. During
step 2, the cue direction determinates the trial “validity”. When the cue points to the
direction of the target trials are “valid” and when the cue points to the direction contrary
of the target trials are “invalid”.
Fig. 2. The graph represents amplitude vs time output for “valid” and “invalid” trials.
Lines show amplitude measured, during 1500 ms of target exposure (step 3 in Fig. 1),
from the central ﬁxation. The top graph is the output for invalid trials, the horizontal
dashed arrow represents latency and the vertical represents amplitude for the trial with a
pink line. The bottom graph is the output for valid trials showing an error with a blue
line. This trial is considered an error because the amplitude of the eye movement was
already approximately 10° when the target appeared (anticipatory).
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threshold of 8500°/s2 with a minimum duration of 12 ms as used in the
previous literature (Macedo et al., 2008, 2011). First saccades (detected
after the target was visible, step 3 in Fig. 1) with amplitude less than
0.6° were ignored (considered microsaccades (Martinez-Conde et al.,
2004)) and the next saccade in the same trial was analysed. Trials were
counted as errors if they meet any of the following criteria: i) the eye
was at the target position before it was presented, ii) latency was above
799 ms (delayed saccades) or below 100 ms (anticipatory saccades).
2.6. Statistical analysis
A minimum of 50% analysed trials was required per subject (20
trials). The eﬀect of group, validity and their interaction was tested with
linear mixed model analysis (IBM SPSS Statistics for Windows, Version
22.0. Armonk, NY: IBM Corp). Linear mixed models are an alternative
to ANOVA with demonstrated advantages when analysing, for example,
reaction times in visual attention experiments (Kliegl et al., 2010). For
the purpose of this study each saccade parameter was deﬁned as
“dependent variable” (e.g. latency). Participants were considered “ran-
dom factors” and “group” (MS fatigue, MS non-fatigue and Control)
were considered “ﬁxed factors”. “Validity” (e.g. valid-cue vs invalid-
cue) was deﬁned as ﬁxed factor. Bonferroni correction was applied
when the number of comparisons was 3 or more. Means described and
in graphs are the estimated marginal means (EMM=mean response for
each factor, adjusted for any other variables in the model) and their
standard errors (SE) for the speciﬁed factors. Correlations between
outcome variables were tested; standard deviation (SD) is also used as
measure of data dispersion.
3. Results
We present the data of 31 participants (19 females) with MS and 31
healthy controls (15 females), in both groups the mean age 36 years
(SD=6). Demographic characteristics of the MS participants, mean
values for FSS, MFIS, and MOCA are reported below. FSS scores were
used to deﬁne two subgroups, the MS fatigue group (FSS score outside
normal range) and the MS non-fatigue. Subjects were considered
fatigued or having impact of fatigue if their score was out of the
normal range for the Portuguese population (Gomes, 2011 Available:
http://hdl.handle.net/1822/17841).
3.1. Neuropsychological results
In the FSS inventory 11 participants (36%, 6 females) were outside
the normal range and were considered fatigued (MS fatigue). The mean
age of the fatigued group was 40 years (SD=4), mean time since
diagnosis was 91 months (SD=57). The mean age for the MS non-
fatigue group was 34 years (SD=6) and time since diagnosis 83 months
(SD=63). In the MFIS, 15 MS participants scored outside the normal
range. The mean MFIS score was 51 (SD=12) for the MS fatigue group
and 20 (SD=16) for the MS non-fatigue.
In the MOCA test both MS groups showed statistically signiﬁcant
diﬀerences when compared with normal values. The MS non-fatigue
group scored 24.9 (SD=2.6, t(19)=−2.6, p=0.017) and the MS fatigue
scored 22.7 (SD=2.1, t(10)=−5.9, p < 0.000). The diﬀerence of 2.2
points between MS groups was statistically signiﬁcant (Mann-Whitney
U test, p=0.03).
3.2. Oculomotor results
The total number of trials analysed was 2122 (13% of the total were
discarded). The median percentage of errors [% of errors=(number of
trials analysed/number of errors)*100] was 2.7% in the control group,
5.4% in the non-fatigue group and 10% in the fatigue group. The
percentage of trials and errors discarded varies largely between studies
and our results are within the expected range (Gorea et al., 2014). The
percentage of errors was higher in both MS groups when compared
with controls (control vs fatigue, chi-square test (1)=5.4, p=0.02, and
control vs non-fatigue, chi-square test (1)=5.2, p=0.022).
The mean latency (EMM for valid and invalid trials values
collapsed) was 240.8 ms (SE=3.8) in MS fatigue group, 223.9 ms
(SE=2.6) in MS non-fatigue group and 225.3 ms (SE=2.0) in the
control group. Results for the saccade latency by validity and group
are shown in Fig. 3. Two main eﬀects were found: i) a main eﬀect of
validity with F(1,1838)=5.2 (p=0.023), latencies were relatively pro-
longed following invalid cues with a mean diﬀerence for valid cues of
7.5 ms(SE=3.3), and ii) a main eﬀect of group, with F(2,1838)=7.8 (p
< 0.001), latencies prolonged for MS fatigue participants. The mean
diﬀerence between MS fatigue and control was 15.5 ms (SE=4.2,
p=0.001), between MS fatigue and MS non-fatigue was 16.9 ms
(SE=4.6, p=0.001). There was not interaction between trial type (valid
vs invalid) and group (control, MS fatigue and MS non-fatigue).
Multiple linear regression was tested with age, BDI, SMDT (correct
responses) and gender. None of these variables showed any signiﬁcant
eﬀects on saccade latency (a separated analysis for valid, invalid and
both was also conducted).
The mean peak velocity (EMM valid and invalid trials collapsed)
was 301.4°/s (SE=4.2) in MS fatigue group, 313.6°/s (SE=2.9) in the
MS non-fatigue group and 323.8°/s (SE=2.2) in the control group.
Results of peak velocity by direction are shown in Fig. 4. For peak
velocity a main eﬀect of group was found, F(2,1838)=27.2 (p < 0.001).
Peak velocity in controls was higher than in the MS non-fatigue, mean
diﬀerence 11.8°/s (SE=2.9, p < 0.001), and higher than in the MS
fatigue, mean diﬀerence 26.2°/s (SE=3.7, p < 0.001). The mean
Fig. 3. Saccade latency for the three groups of participants by validity. MS fatigue (black
columns), MS non-fatigue (grey columns) and control group (white columns). Columns
represent the estimated marginal means (EMM) and error bars their standard error.
Fig. 4. Saccade peak velocity for the three groups of participants by direction. MS fatigue
(black columns), MS non-fatigue (grey columns) and control group (white 10 columns).
Columns represent the estimated marginal means (EMM) and error bars their standard
error.
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diﬀerence between the MS fatigue group and the MS non-fatigue was
14.4°/s (SE=4.0, p=0.01). Peak velocity for right trials was signiﬁcantly
higher than for left trials F(1,1838)=50.5 (p < 0.001), the estimated
diﬀerence between the two directions was 20.7°/s (p < 0.001), there
was no interaction “direction×group” indicating that the asymmetry
(left-right) in peak velocity was equivalent for the 3 groups.
The mean saccade amplitude (EMM valid and invalid trials
collapsed) was 8.9° (SE=0.06) in MS fatigue group, 9.1° (SE=0.04) in
MS non-fatigue group and 8.7° (SE=0.03) in the control group. For
amplitude a main eﬀect of group was found, F(2,1838)=24.9 (p <
0.001), with amplitude signiﬁcantly diﬀerent amongst the 3 groups.
The mean diﬀerence between control group and the MS fatigue group
was 0.17° (SE=0.04, p=0.029) and between control and the MS non-
fatigue was 0.36° (SE=0.05, p < 0.001). The mean diﬀerence MS non-
fatigue and MS fatigue was 0.19 (SE=0.07, p=0.019). There was also an
eﬀect of direction, F(1, 1838)=160 (p < 0.001), with mean amplitude
for left trials of 8.6° (SE=0.04) and for right trials of 9.2°(SE=0.04), the
mean diﬀerence was 0.65° (SE=0.05). There was no interaction
between direction and group. Given the eﬀect of group on amplitude
we computed the mean amplitude for right and for left trials for each
participant. Then we selected the direction with the smaller mean
amplitude and the direction with larger mean amplitude for each
individual and computed the ratio between both. Diﬀerences in this
ratio between the 3 groups were not statistically signiﬁcant (Kruskal-
Wallis H test, p=0.26). These calculations were performed as a control
indicator that diﬀerences for directions were not caused by the
existence of underlying INO in any of the groups.
The relationship between amplitude and peak velocity for 3
participants, one from each group, is shown in Fig. 5. The relationship
between these two variables for the range of amplitudes considered
should be approximately linear (Baloh et al., 1975). The linear ﬁtting is
good for the control subject (squares) but not for the MS non-fatigue
subject (circles) or MS fatigue subject (asterisks).
3.3. Correlations between fatigue and saccades results
There was a positive correlation between the impact of fatigue
(MFIS scores) and the fatigue severity (FSS scores), r=0.71 (p < 0.001)
indicating a strong association between subjective complaints obtained
with inventories. This association indicates that patients with higher
FSS scores report more impact of fatigue in their everyday life,
reinforcing the idea that FSS scores reﬂect a trait.
There was a negative correlation between MOCA scores, r=−0.4
(p=0.014) and MFIS, indicating a mild association between impact of
fatigue and general cognitive functioning. There was also a negative
correlation between SDMT (number of correctly paired symbols) and
latency, r=−0.4 (p=0.033). Fatigue severity (FSS score) was correlated
negatively with peak velocity, r=−0.4 (p=0.028) and amplitude, r=−0.4
(p=0.019), these correlations are shown in Fig. 6.
4. Discussion
In this study we investigated saccadic eye movements in patients
diagnosed with MS using an endogenous generated saccade paradigm.
Saccade latency, peak velocity and amplitude were compared between 3
groups: control, MS fatigue and MS non-fatigue to investigate if they
are altered in MS patients with fatigue complaints. Results conﬁrmed
our prediction that fatigue symptoms would increase saccade latencies
and reduce peak velocities. The functional paradigm used is likely to
capture pre-motor changes in the oculomotor system (Finke et al.,
2012) and requires top-down control of the eye movements (Fielding
et al., 2009; Walker et al., 2000). Previous brain imaging studies
showed that attention areas have altered activity in MS patients with
fatigue symptoms (Filippi et al., 2002; Rocca et al., 2002; Roelcke et al.,
1997). Therefore, we expected to ﬁnd a larger gap between latencies,
according with trial validity, for those with fatigue given the possible
association between fatigue and attention deﬁcits. However, we failed
to ﬁnd this eﬀect.
Patients with fatigue symptoms exhibited increased saccade laten-
cies when compared with patients without fatigue or healthy controls.
Latency results were similar to those reported by Badham and
Hutchinson when studying saccades in people with chronic fatigue
syndrome (Badham and Hutchinson, 2013). Diﬀerences between MS
patients and controls are also in line with other studies (Fielding et al.,
2009; Finke et al., 2012; Walker et al., 1997). The paradigm used is
likely to capture oculomotor problems and diﬃculties to move atten-
tion due to increased internal noise in the neuronal system caused by
fatigue (Prsa et al., 2010; Straube et al., 1997). The negative correlation
between latency and SDMT scores suggests association between latency
and other cognitive performance measures. Evidence of increased
latency caused by fatigue has also been found by Finke et al. in MS
patients (Finke et al., 2012). In that study an exogenous saccade
paradigm that induces fatigue was used and therefore their ﬁndings
could be associated more with fatigability. In addition to the possible
eﬀects of fatigue in attention, we agree with explanation given by Finke
et al. that other factors can contribute to increased latency. According
with these authors eye movements are a measure of the eﬀerent visual
pathway and increased latencies can be explained, for example, by the
impaired central muscle activation observed in patients with fatigue
symptoms (Andreasen et al., 2009; Balcer et al., 2015). Other saccade
measures, such as peak velocity, were consistent with the latency
results.
Decreased saccadic peak velocity has been associated with mental
and muscular fatigue (Schmidt et al., 1979). Our results shown a
signiﬁcant reduction in peak velocity in the MS fatigue group and that
is in line with results obtained in other studies (Finke et al., 2012).
Reduction in saccade peak velocity is likely to provide an accurate
representation of neural activity because, contrary to other saccades
parameters, its control is involuntary (Cazzoli et al., 2014). Animal
studies conﬁrmed that changes in movements’ metrics are likely to be
caused by internal sources of noise such as drowsiness, attention
modulation and neuronal fatigue (Prsa et al., 2010; Straube et al.,
1997). The right – left asymmetry that we found can be explained by
eye dominance (Vergilino-Perez et al., 2012). Peak velocities tend to be
higher to the ipsilateral side of the dominant eye. Approximately 66%
of the population is right eye dominant (Eser et al., 2008) and therefore
peak velocities were higher to right saccades.
Amplitude was diﬀerent between MS groups and controls and was
associated with severity of fatigue. Our amplitude results, for all
groups, are in agreement with the expected saccade hypometria
Fig. 5. The main sequence for 3 participants using valid and invalid trials. Control –
squares, MS non-fatigue – circles, MS-fatigue – asterisks.
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(undershooting the target) when a large saccade of 10° or more is
generated (Leigh and Kennard, 2004). Finke et al. found larger
amplitudes amongst MS fatigue patients than in controls and MS
non-fatigue during parts of the experiment (bin 2). These diﬀerences
changed according with the period considered (Finke et al., 2012).
Fielding et al. compared the gain of ﬁnal eye position (deﬁned as the
ratio between the end point and the amplitude of the stimulus position)
between MS patients and controls. Authors found consistent diﬀer-
ences, although not statistically signiﬁcant, between the two groups for
valid and invalid trials (Fielding et al., 2009). Saccadic hypermetria or
hypometria can be found in 25% or more of patients with MS but its
relationship with fatigue requires further investigation (Barash et al.,
1999; Serra et al., 2003; Tilikete et al., 2011).
We need to acknowledge that our study has some constraints that
might limit the extent of our conclusions. The ﬁrst is the lack of control
for the eﬀect of medication in saccades metrics; the second is that we
were unable to perform reproducibility studies for saccade metrics.
Both limitations can be ﬁlled in longitudinal studies.
In summary, testing saccadic eye movements can help with the
characterization of neurological changes caused by MS as is the case of
fatigue. Eye movement testing can complement the standard inven-
tories because they do not share similar limitations. Future work to
consolidate the main results about this subject should include evalua-
tion of more advanced states of the disease and take in consideration
the limitations pointed above. Paradigms used should aim to disen-
tangle the eﬀect of fatigue from disrupted attention. We believe that
our ﬁndings contribute to the understanding of functional changes
induced by MS and might be useful for clinical trials and treatment
decisions.
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